Coronary heart disease (CHD) is the leading cause of death worldwide with 3.8million men and 3.4 million women dying each year. Cardioprotection refers tothe prevention of CHD and the clinical improvement in patients suffering fromcardiovascular problems. This book focuses on the role of cardioprotection insurgery and the use of pharmacological therapies such as ACE-inhibitors, statins and beta-blockers in order to reduce the myocardial injury sustained by the patient and the significant risk of morbidity and mortality. It includes newcardioprotective strategies aimed at improving the clinical outcomes of patients in these settings, as well as current well-established methods for reducing myocardial injury in acute coronary syndrome patients.
- ISBN: 978-0-19-954476-9
- Editorial: Oxford University
- Encuadernacion: Rústica
- Páginas: 144
- Fecha Publicación: 01/07/2009
- Nº Volúmenes: 1
- Idioma: Inglés